Skip to main content

Habiger David C's Form 4 filing

Boston Scientific CorpBSX · filed May 21, 2026

Accession no.
0001225208-26-005546
Filed
May 21, 2026
Trade date
May 19-20, 2026
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 2 non-derivative transactions. Open-market purchases total $251.1K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Habiger David CCIK 0001326409Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 19, 2026Common StockPPurchaseAcquired+2,200$56.95F1+$125,29011,628Direct
May 20, 2026Common StockPPurchaseAcquired+2,250$55.92F2+$125,82013,878Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Represents the weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $56.93 to $56.96, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

Referenced by the price of 1 transaction in Table I.

F2

Represents the weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $55.85 to $56.00, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)